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Abstract 
Background Ageing and type 2 diabetes mellitus (T2DM) are risk factors for skeletal 
muscle loss. We investigated whether anabolic resistance to feeding might underlie 
accelerated muscle loss in older people with T2DM and whether dysregulated mTOR 
signalling was implicated.  
Subjects 8 obese men with T2DM, and 12 age-matched controls were studied (age 
68±3 vs. 68±6y; BMI: 30±2 vs. 27±5 kg·m-2).  
Methods Body composition was measured by dual-X-ray absorptiometry. Insulin and 
glucose were clamped at post-absorptive concentrations (13±2 vs. 9±3 mU·l-1; 
7.4±1.9 vs. 4.6±0.4 mmol·l-1; T2DM vs. controls). Fractional synthetic rates (FSR) of 
myofibrillar and sarcoplasmic proteins were measured as the rate of incorporation of 
[13C] leucine during a primed, constant infusion of [1-13C] α-ketoisocaproic acid, 3 h 
after 10 or 20g of essential amino acids (EAA) were orally administered. Protein 
expression of total and phosphorylated mTOR signalling proteins was determined by 
Western blot analysis.   
Results Despite a significantly lower appendicular lean mass index and a greater fat 
mass index in T2DM vs. controls, basal myofibrillar and sarcoplasmic and post-
prandial myofibrillar FSR were similar. After 20g EAA, stimulation of sarcoplasmic 
FSR was slightly blunted in T2DM patients. Furthermore, feeding 20g EAA increased 
phosphorylation of mTOR, p70S6k and 4E-BP1 by 60-100% in controls with no 
response observed in T2DM.   
Conclusions There was clear dissociation between changes in mTOR signalling 
versus changes in protein synthesis rates. However, the intact anabolic response of 
myofibrillar FSR to feeding in both groups suggests anabolic resistance may not 
explain accelerated muscle loss in T2DM.  
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Introduction  
Sarcopenia is characterised by a progressive decline in skeletal muscle mass resulting 
in low muscle strength and impaired physical performance [1]. The risk for 
sarcopenia and physical disability is greater in older patients with type 2 diabetes 
mellitus (T2DM) [2]. The biological mechanisms associated with accelerated loss of 
muscle remain uncertain but alterations in skeletal muscle protein turnover are clearly 
implicated in such modifications in T2DM with evidence of impaired stimulation of 
protein synthesis related to ageing and insulin resistance [3, 4].  
We determined whether an impaired anabolic response to feeding (with essential 
amino acids, (EAA)) was evident in skeletal muscle of older patients with T2D and 
whether diminished anabolic sensing and signalling through the PKB/mTOR pathway 
was implicated in any impairment. 
 
Methods  
Participant characteristics Twelve healthy older men and eight men with T2DM were 
recruited (age 68 ± 3 vs. 68 ± 6 y; BMI: 30 ± 2 vs. 27 ± 5 kg·m-2). All subjects gave 
informed written consent and the study was approved by the Tayside Regional Ethics 
Committee (Ref 224/01). Detailed information on inclusion and exclusion criteria is 
reported in the online supplemental material.  
Height and weight were measured and body mass indices and body surface areas 
were determined. Dual energy photon X-ray absorptiometry (DEXA; HOLOGIC 
Discovery W, Bedford, MA) was used to determine whole-body and appendicular 
lean (ALM) and fat (FM) masses.  Age, gender and body mass index (BMI)-specific 
reference curves were used to calculate the individual percentile for height-adjusted 
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ALM (appendicular lean mass index, ALMI) and FM (fat mass index, FMI) 
according to Prado et al [5].   
Experimental protocol (including) Myofibrillar and sarcoplasmic protein FSR under 
basal, post-absorptive conditions (0-3 h) and after stimulation by EAA (3-6 h) were 
measured. In all cases a prior 0.5 h period (-0.5-0 h) ensured a plateau enrichment of 
the stable isotope. A protocol schematic and the composition of the oral EAAs that 
participants were fed is provided in the online supplemental material (Figure S1). 
Analytical methods More detailed information on the analytical procedures are 
reported in the online supplemental material but methods are described briefly below. 
Plasma glucose was measured with a YSI Stat2300 (Yellow Spring Instruments, 
Yellow Spring, OH) immediately after collection of each sample. Insulin was 
determined using an Abbott IMx analyzer (Abbott Inc Deerfield, IL, USA), based 
upon a microparticle enzyme immunoassay. 
The labelling of leucine in plasma and free muscle water was determined by GC-MS 
after conversion to the t- BDMS derivative; the 13C/12C ratio of leucine was 
determined by selected-ion monitoring MS by standard methods as previously 
described. Plasma amino acids were quantified as their t-BDMS derivative after the 
addition of norleucine as internal standard.  
Frozen muscle was processed in buffer containing inhibitors of phosphatase and 
protease activity (e.g. vanadate and microcystine) to maintain the phosphorylation 
state of the sarcoplasmic fraction signalling proteins. Samples (60–80 mg) were 
processed to separate myofibrillar and sarcoplasmic protein as described previously.  
We estimated the relative concentrations and extent of phosphorylation using Western 
blotting in the basal state and after stimulation by EAA examining components of the 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 5
mammalian target of rapamycin (mTOR) signalling pathway, known to be important 
for regulation of mammalian MPS.  
Statistical analysis Patient/subject anthropometric, body composition characteristics 
and biochemical concentrations were compared using an unpaired t-test. One-way 
ANOVA with multiple data sets were applied for the FSR measurements with 
Bonferroni post test procedures for comparison of group means. P was taken as being 
significant at 0.05 or less.  Values are given as mean ± SD. 
 
Results 
Body composition The T2DM group had a significantly greater percentage body fat 
(33±2 vs. 24±5 %; p<0.001) compared to controls but the two groups had similar total 
(P = 0.84) and appendicular lean mass (P = 0.60) (Table S1, online supplemental 
material). However, with application of age, gender and BMI-specific models of body 
composition, significant differences between the two groups emerged using 
percentiles for FMI and ALMI. T2DM patients had higher FMI (49.8±26.4 vs. 
16.0±14.9; P = 0.003) and lower ALMI (34.0±29.5 vs. 66.2±31.3; P = 0.04) 
percentiles compared to the controls, respectively (Figure 1A).  
Biochemical characteristics Fasting plasma glucose and insulin concentration were 
maintained at the post-absorptive concentration throughout the duration of the study. 
There was a significant difference between the plateau glucose and plateau insulin 
concentrations in the T2DM patients and the elderly (both p<0.001) (Figure 2, online 
supplemental material). 
Rates of protein synthesis Basal myofibrillar and sarcoplasmic FSR were similar 
between groups. Myofibrillar FSR was not significantly different after feeding either 
10 or 20 g EAA between the controls and T2DM. The same pattern of anabolic 
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stimulation was observed in controls and T2DM in that 10 g EAA significantly 
stimulated myofibrillar MPS with no additional stimulation with 20 g beyond that 
seen with 10 g EAA (Figure 1B). Sarcoplasmic FSR was similar between the control 
and T2DM after 10 g EAA. After 20g EAA, there was reduced responsiveness of 
sarcoplasmic protein in T2DM compared with the control (Figure 1C). 
Signaling protein analysis In T2DM the concentration of p70S6k was reduced to 
0.76±0.06 of control (P<0.01) but mTOR and 4E-BP1 were similar. Feeding 20 g 
EAA increased phosphorylation of mTOR, p70S6k and 4E-BP1 by 60-100 % without 
any effect in T2DM (P<0.05) (Figure 2). 
 
Discussion 
We have shown that in obese older patients with T2DM and good glycaemic control, 
rates of myofibrillar or sarcoplasmic muscle protein synthesis were similar to those in 
age-matched, non-diabetic individuals. Only the stimulation of sarcoplasmic protein 
synthesis, in response to the highest dose (20 g) of EAA, was blunted in the patients 
with T2DM. Despite the similarity in the anabolic response of MPS to feeding, there 
was diminished phosphorylation of the proteins involved in amino acid 
sensing/signalling pathways, namely mTOR, p70S6k and 4E-BP1 in patients with 
T2DM compared with controls.  
In examining the effects of feeding in T2DM, several pathophysiological 
considerations beyond that of ageing must be accounted for, particularly the degree of 
insulin resistance. Recently there have been conflicting results regarding the 
magnitude of the anabolic response to feeding in non-diabetic individuals in the 
presence of acute lipid-induced insulin resistance. Stephens et al., demonstrated 
anabolic resistance to a bolus of oral amino acids when muscle lipid was increased 
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during a lipid infusion in young men [6]. In contrast, others have found that elevated 
circulating free fatty acid concentrations do not impair the anabolic response to 
feeding [7].  
However, it has been reported that T2DM hyperaminoacidaemia stimulates rates of 
whole body or skeletal muscle protein synthesis to a similar extent to those observed 
in lean and weight-matched control subjects [8]. In the current study, the influence of 
insulin resistance has been removed by maintaining insulin concentrations at their 
respective post-absorptive concentrations to study the isolated effect of 
hyperaminoacidaemia.  
In patients with T2DM, we observed a diminution of the activation of mTOR, p70S6k 
and 4E-BP1, despite apparently similar rates of myofibrillar protein synthesis to those 
in the healthy older people and attenuated rates of sarcoplasmic protein synthesis only 
in response to the highest dose of EAA. We have previously demonstrated that in 
older people, only basal, post-absorptive insulin concentrations accompanying 
ingestion of EAA is required to significantly activate the mTOR signalling pathway 
and so we might expect similar activation of this pathway in both groups [4]. 
Paradoxically, stimulation of MPS in diabetic rats has been demonstrated to occur in 
the absence of increases in the phosphorylation of components of the mTOR pathway 
(4E-BP1 and p70S6k) suggesting there may be alternate, insulin-independent, signal 
transduction pathways that mediate changes in MPS. However we have also noted a 
lack of a coherent response between the activation of signalling proteins regulating 
translation initiation and directly measured rates of protein synthesis in human muscle 
in previous studies [9, 10].  
These findings suggest that the mechanism underlying accelerated muscle loss in 
T2DM does not involve anabolic resistance to feeding. Similarly, evidence of 
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anabolic resistance to exercise in T2DM is lacking considering the findings from 
exercise interventions in obese T2DM in which the magnitude of accretion of 
muscle mass is similar to that observed in healthy controls [12]. Taking these data 
together, it might be speculated that the more pronounced muscle loss in T2DM 
perhaps reflects greater levels of physical inactivity in T2DM compared to age-
matched healthy controls; individuals with T2DM have a demonstrably more 
sedentary lifestyle than age-matched healthy controls [11]. In the absence of 
measures of the participants’ habitual physical activity, the mechanism 
underlying the reduced lean body mass in those with type 2 diabetes versus 
healthy controls can only be speculated in the current study but is likely to 
involve reduced physical activity in those with type 2 diabetes.  
 
In conclusion, we demonstrate that despite evidence of aberrant mTOR signalling 
responses to feeding in obese patients with T2DM, compared to overweight non-
diabetic controls, the anabolic response to feeding is similar in T2DM and controls. 
Thus, the results suggest that anabolic resistance to feeding may not be responsible 
for the accelerated muscle loss observed in T2DM with mechanisms linked to reduced 
physical activity potentially contributory.  
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Figure legends  
Figure 1 Patients with T2DM, despite greater body weight, higher fat mass and a 
higher percentile of fat mass index (FMI) had more pronounced sarcopenia with a 
significantly lower percentile appendicular lean mass index (ALMI) than the healthy 
controls (Fig 1A). Myofibrillar (Fig 1B) and sarcoplasmic (Fig 1C) fractional 
synthesis rates (FSR) in the post-absorptive state and in response to 10 g and 20 g 
EAA, in the healthy elderly (open bars) (n=12) and in patients with T2D (cross-
hatched bars) (n=8). Values are mean ± SD; *P <0.001 compared to fasted; † P < 0.01 
compared to 10 g; ††P < 0.01 compared to old. 
Figure 2 Western blot analysis of phosho-specific mTOR, p70S6k and 4E-BP1 in 
fasting and fed conditions in healthy elderly and T2D in response to 20g EAA. Values 
are mean ± SD; *P <0.05. 
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Figure 2 
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